Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART

European Journal of Ophthalmology

Volumn 16, Issue 5, 2006, Pages 728-732

  Accorinti, Massimo ^a   Pirraglia, M P ^a   Corradi, R ^a   Corsi, C ^a   Fabiani, C ^a   Pivetti Pezzi, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HAART therapy; HIV; Metabolic alterations; Ocular lesions; Retinitis

Indexed keywords

DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE;

ADULT; ARTICLE; CATARACT; CHALAZION; CHORIORETINITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EYE DISEASE; FEMALE; GLAUCOMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION RETINOPATHY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETINA DISEASE; RETINAL MICROANGIOPATHY; RETINITIS; TOXOPLASMOSIS; UVEITIS;

EID: 33845293386     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600511     Document Type: Article

References (22)

1. Kupperman BD, Petty JG, Richmann DD, et al. Correlation between CD4+ counts and the prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related non-infectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993; 115: 575-82.
2. Holland GN. Acquired immunodeficiency syndrome and ophthalmology: the first decade. Am J Ophthalmol 1992; 114: 86-95.
3. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997; 124: 227-33.
4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatients study investigators. N Engl J Med 1998; 338: 853-60.
5. Nussenblatt RB, Lane HC. Human immunodeficiency virus disease: changing pattern of intraocular inflammation. Am J Ophthalmol 1998; 125: 374-82.
6. Pivetti-Pezzi P, Accorinti M. Management of ocular manifestations in patients with acquired immunodeficiency syndrome. Dev Ophthalmol 1999; 31: 192-209.
7. Karavellas MP, Plummer DJ, MacDonald JC, et al. Incidence of immune recovery vitreitis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999; 179: 697-700.
8. Karavellas MP, Song M, MacDonald JC, Freeman WR. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol 2000; 130: 57-64.
9. Kuppermann BD, Holland GN. Immune recovery uveitis. Am J Ophthalmol 2000; 130: 103-6.
10. Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000; 129: 634-9.
11. Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM. Immune recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000; 130: 46-56.
12. Saint Marc T, Partisani M, Poizot-Martin I, et al. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogues therapy. AIDS 1999; 13: 1659-67.
13. Saint Marc T, Partisani M, Poizot-Martin I, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000; 14: 37-49.
14. Tershakovec AM, Frank I, Rader D. HIV-related lipodystrophy and related factors. Atherosclerosis 2004; 174: 1-10.
15. Herman JS, Easterbrook PJ. The metabolic toxicities of antiretroviral therapy. Int J STD AIDS 2001; 12: 555-62.
16. Pivetti-Pezzi P, Tamburi S, Accorinti M, et al. Immunological and viral markers of HIV infection and retinal microangiopathy. Eur J Ophthalmol 1993; 3: 138-42.
17. Pivetti-Pezzi P, Accorinti M, Ciapparoni V, Vullo V. Antiretroviral therapy and HIV-related retinal microangiopathy. AIDS 1997; 11: 1890-1.
18. Kahraman G, Krepler K, Franz C, et al. Seven years of HAART impact on ophthalmic management of HIV-infected patients. Ocul Immunol Inflamm 2005; 13: 213-8.
19. Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye; 20: 703-5.
20. Tsiodras S, Mantzoros C, Hammer S, Samore M. Effect of protease inhibitors on hyperglycemia, hyperlipidemia and lipodystrophy: a 5-year cohort study. Arch Intern Med 2000; 160: 2050-6.
21. Behrens GM, Meyer-Olson D, Stoll M, Schmidt RE. Clinical impact of HIV-related lipodystrophy and metabolic abnormalities on cardiovascular disease. AIDS 2003; 17 (Suppl): S149-154.
22. Van Sighem AI, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003; 17: 2227-36.